BREAKOUT STOCK ALERT
ECOR - electroCore, Inc. - Common Stock
Initial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
ECOR - electroCore, Inc. - Common StockInitial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Bài đăng liên quan
Thông báo miễn trừ trách nhiệm
Thông tin và các ấn phẩm này không nhằm mục đích, và không cấu thành, lời khuyên hoặc khuyến nghị về tài chính, đầu tư, giao dịch hay các loại khác do TradingView cung cấp hoặc xác nhận. Đọc thêm tại Điều khoản Sử dụng.
Bài đăng liên quan
Thông báo miễn trừ trách nhiệm
Thông tin và các ấn phẩm này không nhằm mục đích, và không cấu thành, lời khuyên hoặc khuyến nghị về tài chính, đầu tư, giao dịch hay các loại khác do TradingView cung cấp hoặc xác nhận. Đọc thêm tại Điều khoản Sử dụng.